What are the main strengths of investing in SQZ?

The main strengths of investing in SQZ Biotechnologies Company include: Innovative proprietary cell therapy technology, High potential in emerging medical markets, Strong position in personalized medicine.

What are the potential drawbacks of investing in SQZ?

Potential drawbacks of investing in SQZ Biotechnologies Company include: High volatility in biotechnology stocks, Financial health dependent on clinical trials.

${quote.companyName} (${symbol}) Stock Analysis

Price Chart

Real-time data provided by Alpha Vantage

Financial Metrics

Market Cap

$131.5B

P/E Ratio

N/A

52-Week High

$181.48

52-Week Low

$81.48

Volume

6,218,911

Average Volume

N/A

Dividend Yield

250.00%

Beta

N/A

Key Statistics

Market Cap$131.5B

P/E Ratio (TTM)N/A

Volume6,218,911

Avg VolumeN/A

52-Week High$181.48

52-Week Low$81.48

Dividend Yield250.00%

BetaN/A

ESG Ratings

No ESG ratings available

SQZ Inc.

SQZ

$131.48

SQZ Inc. (SQZ)

Price Chart

Financial Metrics

Key Statistics

ESG Ratings